Ginkgo Bioworks Holdings (DNA) EPS (Basic) Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.12 Bn | 40.04 Bn | 1.44 Bn | -6.64% |
| 2 | Medpace Holdings | 16.34 Bn | 15.83 Bn | 201.64 Mn | 36.50% |
| 3 | Charles River Laboratories International | 13.07 Bn | 12.88 Bn | 452.07 Mn | -101.49% |
| 4 | Icon | 12.37 Bn | 11.44 Bn | 479.29 Mn | -25.56% |
| 5 | Fortrea Holdings | 1.57 Bn | 1.40 Bn | 139.20 Mn | 96.64% |
| 6 | Evotec SE | 626.85 Mn | 200.98 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 421.31 Mn | 336.78 Mn | 18.44 Mn | 31.56% |
| 8 | Champions Oncology | 71.10 Mn | 71.10 Mn | 7.03 Mn | 64.10% |
| 9 | MindWalk Holdings | 59.60 Mn | 51.32 Mn | 1.82 Mn | 86.44% |
| 10 | VivoSim Labs | 1.44 Mn | 1.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.56% |
| Mar 31, 2026 | 17.31% |
| Dec 31, 2025 | 29.73% |
| Sep 30, 2025 | -34.44% |
| Jun 30, 2025 | 74.00% |
| Mar 31, 2025 | 49.35% |
| Dec 31, 2024 | 52.42% |
| Sep 30, 2024 | 82.62% |
| Jun 30, 2024 | -17.91% |
| Mar 31, 2024 | 22.67% |
| Dec 31, 2023 | -5.62% |
| Sep 30, 2023 | 62.21% |
| Jun 30, 2023 | 78.33% |
| Mar 31, 2023 | 70.86% |
| Dec 31, 2022 | 91.27% |
| Sep 30, 2022 | -431.08% |
| Jun 30, 2022 | -63.81% |
| Mar 31, 2022 | -4.17% |
| Dec 31, 2021 | -3,142.69% |
| Sep 30, 2021 | -281.15% |